A prospective comparative study between concurrent chemoradiation with brachytherapy boost with concurrent chemoradiation alone in locally advanced cancer esophagus

CONTEXT: Carcinoma esophagus is a highly malignant disease with very low cure rate. Concurrent chemoradiation is the standard of care in patients deemed unfit for surgery. Intraluminal brachytherapy (ILRT) is effective for palliation of dysphagia and is also used as a boost to external beam radiothe...

Descripción completa

Detalles Bibliográficos
Autor principal: Tudu, Rajanigandha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
ORIGINAL ARTICLE: GI Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956578/
https://www.ncbi.nlm.nih.gov/pubmed/31956613
http://dx.doi.org/10.4103/sajc.sajc_63_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956578/
https://www.ncbi.nlm.nih.gov/pubmed/31956613
http://dx.doi.org/10.4103/sajc.sajc_63_19

Ejemplares similares